Languages
  • Français
  • English
  • Leadership
  • Our Pipeline
    • Viaskin™ Peanut
    • Viaskin™ Milk
    • Viaskin™ Egg
    • Expanded Access Program
    • Scientific Publications & Presentations
  • Viaskin® Platform
  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Financial Information
      • SEC Filings
      • AMF Regulated Information
      • Annual Reports & General Meetings
    • Stock Information
    • Investor FAQs
    • Corporate Governance
      • Board of Directors
      • Audit Committee
      • Compensation Committee
      • Nominating Committee
  • Careers
  • Contact Us
The epicutaneous immunotherapy company
  • Leadership
  • Our Pipeline
    • Viaskin™ Peanut
    • Viaskin™ Milk
    • Viaskin™ Egg
    • Expanded Access Program
    • Scientific Publications & Presentations
  • Viaskin® Platform
  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Financial Information
      • SEC Filings
      • AMF Regulated Information
      • Annual Reports & General Meetings
    • Stock Information
    • Investor FAQs
    • Corporate Governance
      • Board of Directors
      • Audit Committee
      • Compensation Committee
      • Nominating Committee
  • Careers
  • Contact Us

Events

Home » Events
Loading Events

Past Events

  • « Previous Events

January 2021

DBV Technologies Provides Update on Investigational Viaskin™ Peanut for Children Ages 4-11 Years

January 14

Watch the webcast DBV Technologies Conference Call Transcript

View Event

Recent Webcasts

Evercore HealthconX

View All Past Events
  • « Previous Events
+ Export Events
  • About Us
  • Leadership
  • Our Pipeline
  • Viaskin® Platform
  • Investors & Media
  • Contact Us
Follow Us
© 2018 DBV Technologies. All rights reserved.
DBV Technologies therapies are investigational and not FDA approved.
  • Terms of Use
  • Your California Privacy Rights